313 related articles for article (PubMed ID: 33662350)
1. Prognostic value of soluble urokinase plasminogen activator receptor in patients presenting to the emergency department with chest pain suggestive of acute coronary syndrome.
Chenevier-Gobeaux C; Lemarechal H; Doumenc B; Peschanski N; Claessens YE; Borderie D; Ray P
Clin Biochem; 2021 Jun; 92():19-24. PubMed ID: 33662350
[TBL] [Abstract][Full Text] [Related]
2. Soluble urokinase plasminogen activator receptor as a long-term prognostic biomarker in acute coronary syndromes.
Peiró ÓM; Cediel G; Bonet G; Rojas S; Quintern V; Carrasquer A; González-Del-Hoyo M; Sanz E; Bardají A
Biomarkers; 2020 Jul; 25(5):402-409. PubMed ID: 32551985
[No Abstract] [Full Text] [Related]
3. Predictive value of soluble urokinase-type plasminogen activator receptor for mortality in patients with suspected myocardial infarction.
Sörensen NA; Nikorowitsch J; Neumann JT; Rübsamen N; Goßling A; Hartikainen TS; Blankenberg S; Westermann D; Zeller T; Karakas M
Clin Res Cardiol; 2019 Dec; 108(12):1386-1393. PubMed ID: 30989318
[TBL] [Abstract][Full Text] [Related]
4. Value of the soluble urokinase-type plasminogen activator receptor as a predictor of prognosis in patients attended in hospital emergency departments.
Herrero-Puente P; Eugen-Olsen J; Ferreras Amez JM; Gamazo Del Río J; Prieto-García B; de Las Heras-Vallelado A; Arribas Entrala B; González Del Castillo J
Emergencias; 2024 Jan; 36(1):17-24. PubMed ID: 38318738
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic power of soluble urokinase plasminogen activator receptor (suPAR) for short-term mortality in patients seen in Emergency Departments due to infections].
Rubio Díaz R; de Rafael González E; Martín Torres E; Valera Núñez E; López Martos AM; Melguizo Melguizo D; Picazo Perea MP; López García PJ; Fuentes Bullejos P; Chafer Rudilla M; Carretero Gómez JF; Julián-Jiménez A
Rev Esp Quimioter; 2022 Feb; 35(1):50-62. PubMed ID: 34859658
[TBL] [Abstract][Full Text] [Related]
6. Soluble urokinase plasminogen activator receptor for risk prediction in patients admitted with acute chest pain.
Lyngbæk S; Andersson C; Marott JL; Møller DV; Christiansen M; Iversen KK; Clemmensen P; Eugen-Olsen J; Hansen PR; Jeppesen JL
Clin Chem; 2013 Nov; 59(11):1621-9. PubMed ID: 23842203
[TBL] [Abstract][Full Text] [Related]
7. Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trial.
Schultz M; Rasmussen LJH; Kallemose T; Kjøller E; Lind MN; Ravn L; Lange T; Køber L; Rasmussen LS; Eugen-Olsen J; Iversen K
Scand J Trauma Resusc Emerg Med; 2019 Apr; 27(1):43. PubMed ID: 30975178
[TBL] [Abstract][Full Text] [Related]
8. Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Study.
Rasmussen LJH; Ladelund S; Haupt TH; Ellekilde GE; Eugen-Olsen J; Andersen O
Crit Care Med; 2018 Dec; 46(12):1961-1968. PubMed ID: 30247244
[TBL] [Abstract][Full Text] [Related]
9. Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis.
Zhang Q; Li L; Chen H; Zhang G; Zhu S; Kong R; Chen H; Wang G; Sun B
J Clin Lab Anal; 2020 Mar; 34(3):e23097. PubMed ID: 31774228
[TBL] [Abstract][Full Text] [Related]
10. Early Discharge from the Emergency Department Based on Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels: A TRIAGE III Substudy.
Schultz M; Rasmussen LJH; Høi-Hansen T; Kjøller E; Jensen BN; Lind MN; Ravn L; Kallemose T; Lange T; Køber L; Rasmussen LS; Eugen-Olsen J; Iversen KK
Dis Markers; 2019; 2019():3403549. PubMed ID: 31236143
[TBL] [Abstract][Full Text] [Related]
11. suPAR cut-offs for stratification of low, medium, and high-risk acute medical patients in the emergency department.
Santeri S; Peter AA; Kristiina N; Jesper EO; Harri H
BMC Emerg Med; 2021 Nov; 21(1):149. PubMed ID: 34844557
[TBL] [Abstract][Full Text] [Related]
12. Cardio-Renal Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C-Reactive Protein, and Renal Function.
Nikorowitsch J; Borchardt T; Appelbaum S; Ojeda F; Lackner KJ; Schnabel RB; Blankenberg S; Zeller T; Karakas M
J Am Heart Assoc; 2020 Apr; 9(8):e015452. PubMed ID: 32299288
[TBL] [Abstract][Full Text] [Related]
13. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.
Koch A; Voigt S; Kruschinski C; Sanson E; Dückers H; Horn A; Yagmur E; Zimmermann H; Trautwein C; Tacke F
Crit Care; 2011; 15(1):R63. PubMed ID: 21324198
[TBL] [Abstract][Full Text] [Related]
14. Ability of combined soluble urokinase plasminogen activator receptor to predict preventable emergency attendance in older patients in Japan: a prospective pilot study.
Mitsunaga T; Ohtaki Y; Yajima W; Sugiura K; Seki Y; Mashiko K; Uzura M; Takeda S
PeerJ; 2022; 10():e14322. PubMed ID: 36353607
[TBL] [Abstract][Full Text] [Related]
15. Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients.
Geboers DG; de Beer FM; Tuip-de Boer AM; van der Poll T; Horn J; Cremer OL; Bonten MJ; Ong DS; Schultz MJ; Bos LD
Intensive Care Med; 2015 Jul; 41(7):1281-90. PubMed ID: 26100127
[TBL] [Abstract][Full Text] [Related]
16. Soluble Urokinase Plasminogen Activator Receptor (suPAR) in the Emergency Department (Ed): A Tool for the Assessment of Elderly Patients.
Holstein RM; Seppälä S; Kaartinen J; Hongisto M; Hyppölä H; Castrén M
J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743359
[TBL] [Abstract][Full Text] [Related]
17. Soluble Urokinase Plasminogen Activator Receptor as a Decision Marker for Early Discharge of Patients with COVID-19 Symptoms in the Emergency Department.
Stauning MA; Altintas I; Kallemose T; Eugen-Olsen J; Lindstrøm MB; Rasmussen LJH; Gamst-Jensen H; Nehlin JO; Andersen O; Tingleff J
J Emerg Med; 2021 Sep; 61(3):298-313. PubMed ID: 34092446
[TBL] [Abstract][Full Text] [Related]
18. Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study.
Rasmussen LJ; Ladelund S; Haupt TH; Ellekilde G; Poulsen JH; Iversen K; Eugen-Olsen J; Andersen O
Emerg Med J; 2016 Nov; 33(11):769-775. PubMed ID: 27590986
[TBL] [Abstract][Full Text] [Related]
19. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome.
Raggam RB; Wagner J; Prüller F; Grisold A; Leitner E; Zollner-Schwetz I; Valentin T; Krause R; Hoenigl M
J Intern Med; 2014 Dec; 276(6):651-8. PubMed ID: 24645798
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome.
Hoenigl M; Raggam RB; Wagner J; Valentin T; Leitner E; Seeber K; Zollner-Schwetz I; Krammer W; Prüller F; Grisold AJ; Krause R
Clin Biochem; 2013 Feb; 46(3):225-9. PubMed ID: 23159293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
